Morepen Laboratories Limited — Important, 18-03-2025: Agreements

Morepen Laboratories Limited has executed a Business Transfer Agreement (BTA) with its subsidiary, Morepen Medtech Limited, for the hiving-off of its Medical Devices Business on a ‘slump sale’ basis. This strategic move is aimed at streamlining operations and enhancing focus on core business activities. The agreement transfers all rights, title, and interest in the undertaking, with the final consideration subject to adjustments post-valuation in accordance with relevant tax rules. Importantly, this transaction is categorized as a related party transaction, as Morepen Medtech Limited is a subsidiary with 80% ownership by Morepen Laboratories. This divestiture could improve operational efficiency and align Morepen’s resources towards more profitable segments, presenting a potentially positive outlook for investors. Watch closely for how this strategic refocus plays out in future financial results.